Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Peli Continues Enhancement of Cold Chain Industry

Published: Tuesday, April 23, 2013
Last Updated: Tuesday, April 23, 2013
Bookmark and Share
Company acquires renowned Minnesota Thermal Science, the industry leader of temperature controlled transportation products.

Peli Products, Inc. has announced the acquisition of Minnesota Thermal Science (MTS), the industry leader in global temperature controlled transportation products.

Based in Plymouth, Minnesota, MTS will merge with Peli’s already established BioPharma™ division.

“The combined entity will offer customers an even wider range of the most advanced temperature controlled packaging solutions for the safe transport of pharmaceuticals, tissue, biologics, diagnostics, blood and other healthcare products,” said Lyndon Faulkner, President and CEO of Peli.

Faulkner continued, “The award-winning thermal protection products of MTS will be matched with Peli’s global capabilities providing a worldwide solution of re-usable transportation and packaging products and services.”

In addition to Peli BioPharma cases that offer 140+ hours between 2.0 to 8.0C, customers will have access to the full suite of MTS products including the reusable Credo Cube®, which protects payload contents at defined temperatures longer than any other passive thermal shipper.

Equally impressive are the Credo Xtreme® full pallet which holds 890 litres and the half pallet which holds 406 litres, each providing 35 percent more payload space than the closest competitor.

In addition to their unique scientific packaging, MTS offers a complete range of services and software to support a reusable temperature controlled packaging solution.

“Joining forces with Peli will enable us to aim even higher and provide customers with an unmatched global cold chain solution under one company”, said Tom Anderson, CEO of MTS.

Anderson continued, “We’re confident that together we’ll deliver products and services to the industry better than any competitive offering. An accelerated product development programme which will significantly enhance the combined company’s solution set and associated cold chain services is already underway.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!